Drug Formulation with Cyclodextrins

Velesco is a niche contract research organization (CRO) specializing in early phase drug development.  One of our core competencies is formulation of compounds for early toxicology studies.  We take a targeted, scientific approach to pharmaceutical formulation.

 

One of our tools for formulation of poorly soluble early stage compounds is the family of cyclodextrins.

 

To learn more about how Velesco is utilizing cyclodextrins in early phase drug development, download our free whitepaper describing cyclodextrins and how they can be used as early stage solubilizers.

News and Events

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing

  

New job posting! Careers 

Velesco has been awarded a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment of Beta-Thalassemia through the NCATS! Read the press release here.

  

We celebrated our 10th anniversary in 2017!

  

Velesco's work published in

a Drug Development & Delivery article!

Read it here.

  

Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100

 

734-527-9125